# Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam

> **NCT06563063** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 60 (actual)

## Conditions studied

- Stomach Neoplasm

## Interventions

- **DRUG:** Flumazenil

## Key facts

- **NCT ID:** NCT06563063
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-23
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06563063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06563063, "Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06563063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*